vimarsana.com

டிரான்சியா உயிர் மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology, End User -Forecast to 2025 – KSU

Transasia augments COVID relief efforts to various state govts

Transasia augments COVID relief efforts to various state govts Transasia augments COVID relief efforts to various state govts 02 June 2021 | News Donates 200 BiPAP machines to state governments apart from 40 cell counters and 30 coagulation analysers Transasia Bio-Medicals has stepped up its efforts to augment the capacity of various state governments to provide timely oxygen support to their citizens. Transasia has arranged to provide 200 BiPAP machines, to be distributed to various COVID-dedicated hospitals across India. The company has procured BiPAP machines from its global vendors. Transasia has already pledged the BiPAP machines to several beneficiaries through the state governments in Delhi, Uttar Pradesh (Lucknow and Raebareli), Rajasthan (Jaipur and Ajmer), West Bengal, Assam, Agartala, Maharashtra (Mumbai and Panchgani), Karnataka (Chikkamagaluru, Tumkur, Udupi, Chitradurga and Vijayapura), Telangana and Tamil Nadu. This initiative has been very well received

Urine Analyzers Market Set for Rapid Growth and Trend by 2021-2026 – KSU

1) North America- (United States, Canada) 2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium) 3) Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam) 4) Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria) 5) Latin America- (Brazil, Mexico, Argentina, Colombia, Chile, Peru). Highlights following key factors: :- Corporate strategy – Analyst’s summarization of the company’s business strategy. :- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. :- Company history – Progression of key events associated with the company. :- Major products and services – A list of major products, services and brands of the company.

Transasia opens facility at AMTZ

Transasia opens facility at AMTZ Updated: Updated: COVID test kits to be manufactured Share Article COVID test kits to be manufactured Transasia Bio-Medicals Ltd. on Thursday announced the formal inauguration of its state-of-the-art medical devices manufacturing plant at the Andhra Pradesh MedTech Zone (AMTZ) here. The largest of its kind facility in Asia spread over 35,000 sft will manufacture ErbaLisa COVID-19 IgG ELISA test kits, RT-PCR kits and rapid test kits for India and other emerging markets. The new facility was virtually inaugurated by Minister for Industries, Commerce and IT Mekapati Goutham Reddy, Telecommunications Regulatory Authority of India (TRAI) chairperson P.D. Vaghela, Scientific Secretary to Principal Scientific Adviser, Government of India, Arabinda Mitra, Special Chief Secretary to Government (Industries and Commerce) R. Karikal Valven, in the presence of MD and CEO of AMTZ Jitendra Sharma, founder and chairman of Transasia-Erba International Group of

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.